
Sign up to save your podcasts
Or


Biotech might produce the world’s next trillion-dollar company—and Simba Gill and Steve Ledger are betting on it. Join Jess Larsen as he explores how Serina Therapeutics’ drug optimization platform could reshape the future of treatment for Parkinson’s, cancer, and beyond. Simba, with four decades of biotech leadership, and Steve, with roots in finance and venture, share how science, capital, and mission come together to drive massive impact. This is a behind-the-scenes look at what happens when breakthrough science collides with visionary leadership.
Learn more about your ad choices. Visit megaphone.fm/adchoices
By Graystoke Networks4.6
303303 ratings
Biotech might produce the world’s next trillion-dollar company—and Simba Gill and Steve Ledger are betting on it. Join Jess Larsen as he explores how Serina Therapeutics’ drug optimization platform could reshape the future of treatment for Parkinson’s, cancer, and beyond. Simba, with four decades of biotech leadership, and Steve, with roots in finance and venture, share how science, capital, and mission come together to drive massive impact. This is a behind-the-scenes look at what happens when breakthrough science collides with visionary leadership.
Learn more about your ad choices. Visit megaphone.fm/adchoices

30,689 Listeners

43,711 Listeners

3,454 Listeners

8,770 Listeners

4,366 Listeners

2,319 Listeners

2,138 Listeners

8,985 Listeners

9,628 Listeners

662 Listeners

1,285 Listeners

5,565 Listeners

667 Listeners

3,212 Listeners

1,428 Listeners